Manufacturing briefing: After J&J-Emergent mixup, fewer doses expected in US next week; Boehringer taps Oxford for viral vectors
Americans will see a significant drop in J&J Covid-19 vaccines allocated next week, according to data from the CDC.
A report from Reuters noted that just 785,500 doses will be doled out, compared to 4.95 million this week.
The New York Times previously reported that a mixup at a Baltimore Emergent facility resulted in 15 million future doses being ruined. California is the main recipient of the J&J vaccine, followed by Texas and Florida, Reuters said.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
